Dr. Lindsay Kilburn, MD
Claim this profileChildren's National Medical Center
Studies Brain Tumor
Studies Recurrence
14 reported clinical trials
23 drugs studied
Area of expertise
1Brain Tumor
H3.3K27M positive
Stage I
Stage II
2Recurrence
Stage I
Stage II
IDH positive
Affiliated Hospitals
Clinical Trials Lindsay Kilburn, MD is currently running
Individualized Treatment
for Medulloblastoma
The current study will use a new treatment approach based on the molecular characteristics of each participant's tumor. The study will test the feasibility of performing real-time drug screening on tissue taken during surgery, and of having a specialized tumor board assign a treatment plan based on the results of this screening and genomic sequencing. The aim of this trial is to allow every child and young adult with medulloblastoma to receive the most effective and least toxic therapies currently available, and will pave the way for improved understanding and treatment of these tumors in the future.
Recruiting1 award N/A
Pembrolizumab
for Pediatric Brain Cancer
This trial studies the safety and effectiveness of pembrolizumab in younger patients with aggressive or treatment-resistant brain tumors. Pembrolizumab is an immunotherapy drug that helps the immune system attack cancer by blocking a protein that stops immune cells from working effectively. Pembrolizumab has been used in various cancers, showing effective antitumor activity and is approved by the FDA for multiple uses.
Recruiting1 award Phase 124 criteria
More about Lindsay Kilburn, MD
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Lindsay Kilburn, MD has experience with
- Nivolumab
- Trametinib
- Fimepinostat
- Therapeutic Conventional Surgery
- Tovorafenib/DAY101
- K27M Peptide
Breakdown of trials Lindsay Kilburn, MD has run
Brain Tumor
Recurrence
Diffuse Intrinsic Pontine Glioma
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lindsay Kilburn, MD specialize in?
Lindsay Kilburn, MD focuses on Brain Tumor and Recurrence. In particular, much of their work with Brain Tumor has involved H3.3K27M positive patients, or patients who are Stage I.
Is Lindsay Kilburn, MD currently recruiting for clinical trials?
Yes, Lindsay Kilburn, MD is currently recruiting for 8 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Lindsay Kilburn, MD has studied deeply?
Yes, Lindsay Kilburn, MD has studied treatments such as Nivolumab, Trametinib, Fimepinostat.
What is the best way to schedule an appointment with Lindsay Kilburn, MD?
Apply for one of the trials that Lindsay Kilburn, MD is conducting.
What is the office address of Lindsay Kilburn, MD?
The office of Lindsay Kilburn, MD is located at: Children's National Medical Center, Washington, District of Columbia 20010 United States. This is the address for their practice at the Children's National Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.